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ABSTRACT 
Objective: The aim of this study is to develop a simple, precise and accurate analytical method of deoxyarbutin in anhydrous emulsion system preparation.  
Methods: The analysis was conducted using high-performance liquid chromatography (HPLC). Chromatographic analysis was carried out using a 
reversed phase-C18 column. The mobile consists of two phases methanol and water (60: 40 v/v) at a flow rate of 1.0 ml/min. The determinations 
were performed using UV detector set at 225 nm. All validation procedures were added with hydroquinone as an internal standard.  
Results: The method showed coefficient correlation is 0.9978, relative standard deviation (RSD) smaller than 2%, Limit of Detection (LOD) and 
Limit of Quantitation (LOQ) are 0.599 µg/ml and 1.817 µg/ml respectively. The total amount deoxyarbutin in anhydrous emulsion preparation is 
1.964+0.02 % with 98% recovery percentage.  
Conclusion: The developed HPLC analytical method meets the validation criteria made by International Conference on Harmonisation (ICH).  
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Deoxyarbutin was first synthesized in 2005 by Boissy and his team. 
This compound is synthesized from its parent compound arbutin by 
removing the hydroxy group on the glucose side chain [1]. 
Deoxyarbutin is a novel depigmentation agent which has tyrosinase 
inhibitor activity. This compound inhibits melanin synthesis in 
melanogenesis [2]. Excessive melanin accumulation causes 
hyperpigmentation. This condition is not considered cosmetically 
pleasing to most people [3]. Hyperpigmentation is the changing of 
the color intensity of the skin to darker, which is due to an increased 
amount of melanin in the epidermis, the dermis, or both. This 
change can be due to 2 pathophysiologic processes: melanocytosis 
(increased number of melanocytes) and melanosis (increased 
amount of melanin). Skin lightening agents work best when 
melanosis or melanocytosis is confined to the epidermis [4, 5]. A 
strategy for the treatment of hyperpigmentation conducted through 
a depigmentation agent [6]. Skin depigmentation agents are widely 
developing through inhibition of tyrosinase enzyme [7]. The 
tyrosinase enzyme is responsible for catalyzing the conversion of L-
tyrosine into L-DOPA in melanogenesis, inhibition of tyrosinase 
enzyme causing disruption of melanin formation [8]. Deoxybarbutin 
has been shown to have better activity than other tyrosinase 
inhibitor agents and also safer [1, 8]. Some depigmentation agents 




Fig. 1: Chemical structure of deoxyarbutin 
 
In previous studies, it was stated that deoxyarbutin is thermolabile 
in aqueous solution and decomposes into hydroquinone. Instability 
in water is a problem if formulated in conventional emulsions. 
Therefore, to enhance the stability, the aqueous phase formulated to 
an anhydrous, non-aqueous, oil-in-oil or oil-polar solvent emulsion 
system [13-14]. In this preparation, we choose polyol-in-oil 
anhydrous emulsions for the analysis. Propylene glycol and glycerin 
provide the solubility of deoxyarbutin. The oil phase is produced by 
adding cyclomethicone with stearyl dimethicone and isostearyl 
isostearate. The major objective of this study was to obtain a simple, 
rapid and accurate analytical method deoxyarbutin in the anhydrous 
emulsion system. Method development was conduct with high-
performance liquid chromatography (HPLC). An internal standard 
method is used for methodological development. 
MATERIALS AND METHODS 
Chemical reagent 
Materials 
Deoxyarbutin (Nardev Chemie), Hydroquinone (Xilong Chemical) as 
an internal standard, Methanol pro-HPLC (Merck), aquabidest (IPHA 
Laboratories), cetyl dimethicone copolyol, cyclomethicone, stearyl 
dimethicone, isostearyl isostearat, propylene glycol and glycerin. 
Apparatus and chromatographic conditions 
HPLC (Shimadzu) with UV detector (Shimadzu), analytical scales 
(Ohauss Pioneer), ultrasonic bath (NEY 1510), C18G Enduro column 
(SGE analytical) with a C18 guard column (SGE analytical), micro 
filter syringe (Hamilton Co.) and LC solution for data interpretation. 
The HPLC system operated at 25 °C with methanol and water (60: 
40 v/v) as mobile phase with isocratic elution. The flow rate is 1 
ml/min. The injection volume is 10 µl. UV detection performed at 
225 nm. The total run time for HPLC analysis is 8 min. 
Methods 
Preparation of standard solution 
Stock standard of deoxyarbutin (500 µg/ml) and hydroquinone (500 
µg/ml) were prepared by dissolving 25 mg deoxyarbutin and 
hydroquinone in 50 ml mobile phase and stored in the refrigerator. 
The working solution was made by diluting the stock standard 
solution in the mobile phases into several concentrations of 6.25, 
12.5, 25, 50, 80, 100, 120 and 200 µg/ml. All working standards 
contain internal standard hydroquinone 25 µg/ml. 
Mobile phase preparation 
The mobile phase consists of methanol and water (60:40 v/v). The 
mobile phase was degassed to remove air bubbles in the mobile 
phase. The mobile phase was filtered using a 0.45 μm membrane 
filters after sonicated using ultrasonic for 10 min. 
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Procedure validation with HPLC method 
The validation method was developed according to ICH (Q2) guideline 
validation of analytical procedures [15]. System suitability was 
conducted by injecting six replicated standards of deoxyarbutin. 
Linearity was observed using six solutions concentration of standard 
(6.25, 12.5, 25, 50, 100 and 200 µg/ml). Accuracy (recovery) was 
determined using three levels concentration of standard deoxyarbutin 
80, 100 and 120 % (80, 100, 120 µg/ml) with three replications. The 
precision was investigated by respect to repeatability (intra-day 
precision) and intermediate precision (inter-day variation) by measured 
concentration of standard deoxyarbutin 100 % (100µg/ml) with six 
replications. The limit of detection (LOD) and limit of quantitation (LOQ) 
of deoxyarbutin were determined based on the standard deviation (σ) of 
response and slope (s). All standard concentrations of deoxyarbutin for 
validation procedure spiked with internal standard hydroquinone 25 
µg/ml and excipient of preparation or placebo.  
The analysis of deoxyarbutin in anhydrous emulsion preparation 
A cream sample (2.5 g) was dissolved in 100 ml methanol and then 
sonicated for 30 min. 2.5 ml sample diluted with 25 ml of mobile 
phase. The sample was filtered by a membrane filter of 0.45 μm and 
injected to HPLC system. 
RESULTS AND DISCUSSION 
Method development and optimization 
The choice of the mobile phase is generally based on the polarity index 
(P '), hence it can elute the analyte from the column. The higher P 
value indicates the more polar mobile phase. To get the mobile phase 
with medium polarity, a combination of two or more mobile phases is 
performed. The mobile phase used is a combination of methanol and 
water. Methanol is a semipolar solvent. The polarity index of methanol 
and water respectively 5.1 and 10.2 [16]. Deoxyarbutin is a 
hydrophobic compound because the hydroxy group removed from the 
side chain of the glucose group of the parent compound, arbutin [1]. 
Deoxyarbutin can dissolve in methanol with the solubility of 667 g/L 
at 24 °C. Hydroquinone used as an internal standard has more polar 
properties than deoxyarbutin with a log P value of 0.59 at a 
temperature of 25 °C (PubChem CID 785).  
The combination of methanol and water with a 60: 40 composition 
can dissolve and remove both deoxyarbutin and hydroquinone from 
the column. The column used for separated deoxyarbutin and 
hydroquinone is reversed phase column C18. In the reverse phase 
column, the stationary phase is octadecyl silica. It is caused by non-
polar compounds to be absorbed in the column longer. Therefore, in 
this analysis, hydroquinone is eluted prior to deoxyarbutin. The use 
of guard columns is aimed to protect the column from damage 
caused by chemical contamination, without affecting the results of 
the analysis. Contamination or impurity can be carried by the mobile 
phase contaminated from samples, solvents, or substances from the 
pump. The existence of this contamination causes disturbances, such 
as high back pressure, formed peaks that are divided or expanded, 
the disturbed baseline either drifts or decreases, and the most 
common is the change in resolution or separation of the columns.  
Analytical method validation with HPLC was developed by internal 
standard method. Internal standard methods are used to improve 
the precision and accuracy of results where volume errors are 
difficult to predict and control the analytical methods [17]. The error 
of analysis is caused by injection errors, solvent evaporation and the 
preparation in the analytical procedure. In this study, hydroquinone 
is chosen as an internal standard. UV detector sets at 225 nm to 
detect deoxyarbutin and hydroquinone. Both of these compounds 
have a chromophore group that can be detected on UV wavelength.  
In this study, a simple mixed of mobile phase containing methanol: 
water (60:40 v/v) can separate these two compounds within 8 min 
in its preparation. Methanol has intermediate polarity and 
combination with water can elute this hydrophobic compound from 
C18 Column [18]. This method is more efficient compared to several 
studies which examine the separation of deoxyarbutin and 
hydroquinone using HPLC with a conditioned mobile phase, such as 
methanol and water at 80:20 (v/v) and acetonitrile-water-formic 
acid at the various ratio and with spectrophotometric method [19]. 
Validation methods 
System suitability test (SST) is an essential feature in analytical 
method validation. SST mainly determines Resolution (R), 
repeatability (RSD-relative standard deviations of peak response and 
retention time), column efficiency (N), capacity factor and tailing 
factor (T) [15]. SST is generally performed to evaluate the suitability 
and the effectiveness of the entire chromatographic system. Not only it 
is initially used but also used during the analysis. The proposed 
method meets these requirements within the accepted limits as shown 
in table 1. The chromatogram standard deoxyarbutin and IS 
hydroquinone is described in fig. 2. Deoxyarbutin and hydroquinone 
are separated completely, and there is no interference placebo 
preparation or matrix on their chromatogram. 
  
 
Fig. 2: Chromatogram standard of deoxyarbutin 50 µg/ml (5.237 min) and internal standard hydroquinone 25 µg/ml (2.017 min). The X-
axis is retention time and Y-axis is AUC 
 
Table 1: Results of parameters of system suitability test 
Parameters Recommended limit Result 
Hydroquinone Deoxyarbutin 
Injection repeatability (n = 6) RSD<2 % for n ≥ 5 RSD of area: 0.146 % 
RSD of retention time: 0.06 % 
RSD of area: 0.197 % 
RSD of retention time: 0.121 
Plate number (N)  N>2000 2,508 4,592 
Capacity factor (K) 2 <k'<10 0.299 2.192 
Tailing factor (T) T ≤ 2 1.17 1.16 
Muchtaridi et al. 
Int J App Pharm, Vol 11, Issue 2, 2019, 172-175 
174 
Linearity was studied using six standards of deoxyarbutin spiked with IS 
hydroquinone. Each variation concentration was injected into HPLC 
system in triplicate. The calibration curve was constructed by plotting 
between ratio concentration of deoxyarbutin (x) and hydroquinone and 
ratio peak area (y). The correlation coefficient (r2
 
 = 0.9978) obtained for 
the regression line demonstrates that there is a strong linear relationship 
between peak area and concentration of deoxyarbutin (fig. 3). Limit of 
Detection (LOD) and Limit of Quantification present the sensitivity of the 
analytical method. LOD is the point at which a measured value is larger 
than the uncertainty associated with it. It is the lowest concentration of an 
analyte in a sample that can be detected, but not necessarily quantified. 
LOQ is the minimum injected amount that produces quantitative 
measurements in the target matrix with acceptable precision in 
chromatography, typically requiring peak heights 10 to 20 times higher 
than the baseline noise. LOD and LOQ were calculated by using the 
following equations: LOD = (3.3 σ/s), LOQ = (10 σ/s) [19]. LOD and LOQ 
deoxyarbutin in this analytical method are found consecutively 0.599 
µg/ml and 1.817 µg/ml. 
 
Fig. 3: Calibration curve of deoxyarbutin with an internal standard method 
 
Repeatability (intra-day) and intermediate precision (inter-day 
variation) are shown in table 2. Precision is presented as % RSD. 
Precision was determined by placebo spiked method. % RSD for 
repeatability is 1.90 % and % RSD for intermediate precision is 1.27 %. 
  
Table 2: Result repeatability and intermediate precision 
Precision  Parameters Concentration (µg/ml) Acceptance criteria Results 
(mean±SD) 
Repeatability % RSD  100 % RSD<2  1.90 ±1.93  
Intermediate precision % RSD  100 % RSD<2 1.27 ± 0.56  
*Precision value is represented as a mean±SD (standard deviation) of 6 observation (n=6) on level 100 %.  
 
Table 3: Recovery studies deoxyarbutin with placebo spiked method 
Level (%) Deoxyarbutin added (mg) Deoxyarbutin founded (mg) Recovery (%) (mean±SD) 
80 39.8 37.5 96.3 + 1.19 
40.0 38.9 
40.2 39.2 
100 50.1 51.6 102.4 + 0.6 
50.2 51.1 
50.1 51.4 
120 59.9 59.2  
97.8 + 0.9 59.8 58.0 
59.8 58.4 
*Accuracy value is represented as a mean±SD (standard deviation) of 3 observation (n=3) each level.  
 
The aim of study accuracy is to investigate the analytical method 
that is able to provide accurate result value. Accuracy can also be 
described as the closeness between the founding value and the true 
value. Accuracy reported by percentage recovery. Same as the 
precision study, accuracy is determined by placebo spiked method. 
Accuracy meets criteria validation. As the result of recovery 
percentage shown in table 3. 
Analysis deoxyarbutin in anhydrous emulsion preparation 
Table 4 shows the level of deoxyarbutin in anhydrous emulsion 
preparation. 2.5 g emulsion is dissolved in 100 ml methanol, and 
added by 25µg/ml internal standard hydroquinone. Methanol 
solvent used for extracting deoxyarbutin from other components 
[12]. To speed up the extraction process, the process is assisted by 
sonication, using ultrasonic for 15 min. Sonication aims to increase 
the homogeneity of dissolving particles that may still be present in 
the matrix by increasing kinetic energy from the particle. 2.5 ml 
samples are diluted with 25 ml of mobile phase. The sample is 
filtered by a membrane filter of 0.45 μm and injected to HPLC 
system. The deoxyarbutin concentration in preparation is 
determined by making a substitution of the peak area ratio between 
deoxyarbutin and hydroquinone to regression linear. The total of 
deoxyarbutinin anhydrous emulsion preparation (n=3) is 1.96±0,02 
% with 98% recovery. 
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Table 4: The content of deoxyarbutin in anhydrous emulsion preparation 
Replication # Peak area Ratio peak area Percentage of Deoxyarbutin (%) 
Deoxyarbutin Hydroquinone  
1 650336 221654 29.34 1.96 
2 632034 215087 29.39 1.96 
3 681584 231874 29.39 1.96 
mean±SD 1.964±0.02 % 
*Concentration deoxyarbutin in the formulation is 2 %. Total deoxyarbutin founded in the formulation represented as a mean±SD (standard 
deviation) of 3 observations. 
 
CONCLUSION 
The developed HPLC analytical method meets the validation criteria 
made by ICH. The optimum condition is performed using column C-
18, UV detector 225 nm, methanol: water (60:40 v/v) as the mobile 
phase with isocratic elution, the flow rate at 1 ml/min and running 
time is 8 min. Total deoxyarbutin was found in anhydrous emulsion 
preparation is 1.964±0.02 % with 98% recovery percentage. 
AUTHORS CONTRIBUTIONS 
All the authors have contributed equally. 
CONFLICT OF INTERESTS 
Declared none 
REFERENCES 
1. Boissy RE, Visscher M, DeLong MA. Deoxy arbutin: a novel 
reversible tyrosinase inhibitor with effective in vivo skin 
lightening potency. Exp Dermatol 2005;14:601-8. 
2. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. 
Nature 2007;445:843-50. 
3. Tai SS, Lin CG, Wu MH. Evaluation of depigmenting activity by 
8-hydroxydaidzein in mouse B16 melanoma cells and human 
volunteers. Int J Mol Sci 2009;10:4257-66. 
4. Surini S, Mellani T. Formulation and physical evaluation of 
microemulsion and W/O/W multiple emulsions dosage forms 
with alpha arbutin, lactic acid, and niacinamide as skin-
whitening cosmetics. Int J Appl Pharm 2017;9:67-90. 
5. Mukul S, Surabhi K, Atul N. Cosmeceuticals for the skin: an 
overview. Asian J Pharm Clin Res 2011;4:1-6. 
6. Arsiwala S, Tahiliani S, Jerajani H. Evaluation of image blanc 
complexion lighter and image blanc spot lightener for 
hyperpigmentation in face and neck. Asian J Pharm Clin Res 
2013;6:90-3. 
7. Briganti S, Camera E, Picardo M. Chemical and instrumental 
approaches to treat hyperpigmentation. Pigment Cell Res 
2003;16:101-10. 
8. Videira IF, Moura DF, Magina S. Mechanisms regulating 
melanogenesis. An Bras Dermatol 2013;88:76-83. 
9. Hu ZM, Zhou Q, Lei TC. Effects of hydroquinone and its glucoside 
derivatives on melanogenesis and antioxidation: biosafety as skin 
whitening agents. J Dermatol Sci 2009;55:179-84. 
10. Petit L, Pierard GE. Skin-lightening products revisited. Int J 
Cosmet Sci 2003;25:169-81. 
11. Kim YJ, Uyama H. Tyrosinase inhibitors from natural and 
synthetic sources: structure, inhibition mechanism and 
perspective for the future. Cell Mol Life Sci 2005;62:1707-23. 
12. Yang CH, Chang NF, Chen YS. Comparative study on the 
photostability of arbutin and deoxy arbutin: sensitivity to 
ultraviolet radiation and enhanced photostability by the water-
soluble sunscreen, benzophenone-4. Biosci Biotechnol Biochem 
2013;77:1127-30. 
13. Suitthimeathegorn O, Jaitely V, Florence AT. Novel anhydrous 
emulsions: formulation as controlled release vehicles. Int J 
Pharm 2005;298:367-71. 
14. Carvalho VF, de Lemos DP, Vieira CS. Potential of non-aqueous 
microemulsions to improve the delivery of lipophilic drugs to 
the skin. AAPS PharmSciTech 2017;18:1739-49. 
15. International Conference on Harmonization I. Validation of 
analytical procedures: Text and Methodology, Q2(R1). 
Switzerland, Geneva; 1994. 
16. Synder LR. Practical HPLC method development Second 
Edition New York: Jhon Willey and Sons inc; 1997. 
17. Karyn MU, Steven W Hansen, Jennifer S Amoo, Allison P 
Bernstein, Mary Ellen P McNally. Precision of internal standard 
and external standard methods in high-performance liquid 
chromatography. LCGC Magazine. Rio de Janeiro; 2015. 
18. Muchtaridi M, Musfiroh I. Off-line SPE-GC/MS analysis of lead 
compounds aromatherapy in blood plasma of mice of essential 
oils materials from indonesian aromatic plants. Asian J Chem 
2012;24:5124. 
19. Kurniati Y, Aryanti AD, Ramdhani D. Design of hydroquinone 
indicator strip based on polymethylmethacrylate (Pmma) for 
identification of hydroquinone in whitening cosmetics: a case study 
in bandung indonesia. Int J Pharm Pharm Sci 2016;8:354-9. 
20. Ermer J. Method validation in pharmaceutical analysis. 
Analytical Validation within the Pharmaceutical Environment. 
In: Ermer J Miller JHMcB. Weinheim: Wiley-VCH Verlag GmbH 
and Co. KGaA; 2005. 
 
